Cosaldon retard in the treatment of certain maculopathies
Starzycka, M.; Krukar-Bastrowa, K.
Klinika Oczna 82(6): 315-316
1980
ISSN/ISBN: 0023-2157 PMID: 7406972 Document Number: 166569
Document emailed within 1 workday
Related Documents
Koeppen, G.; Schmidt-Modrow, G. 1979: Treatment of cardiac and cerebrovascular insufficiency with Card-Cosaldon. Result of a field study Therapie der Gegenwart 118(11): 1704-1713Ogielska, E.; Koziorowska, M. 1975: Maculopathies as a late complication of surgical treatment of retinal detachment Klinika Oczna 45(10-11): 1181-1184
Hruby, K. 1974: Treatment of senile degenerative maculopathies by etaretin. Prospects of success and economical points of view Klinische Monatsblatter für Augenheilkunde 165(1): 68-70
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z. 1985: Comparison of the biological availability of retard and non-retard lisuride tablets in dogs Ceskoslovenska Farmacie 34(1): 3-6
Sampedro, A.; Alonso Alvarez, C.; Ruiz Rodríguez, M.; Usabiaga Bernal, J.M.; Rodríguez Vázquez, M. 2001: Traumatic maculopathies Archivos de la Sociedad Espanola de Oftalmologia 76(1): 57-60
Heckrodt, K. 1979: Treatment of acoustic trauma with Cetal retard Medizinische Klinik Suppl: 55-56
Koeppel, F.W. 1976: Treatment of sound perception deafness with Danaden retard Münchener Medizinische Wochenschrift 118(32-33): 1015-1016
Kopp, H. 1972: Treatment of latent heart insufficiency by Eoden-retard Zeitschrift für Allgemeinmedizin 48(35): 1653-1656
Klensch, H.; Hoffmann, H.R. 1975: Neurophysiologic control during treatment of cerebral ischaemia with danaden retard Medizinische Klinik 70(26): 1133-1138
Pivac, N.; Dobovisek, J.; Bagatin, J.; Gros Furek, V.; Rumboldt, Z.; Janezić, A.; Kveder, R.; Sjerobabski, V.; Simunić, M.; Sardelić, S. 1993: Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension Lijecnicki Vjesnik 115(11-12): 356-359
Bartels, H. 1977: Treatment of cerebrovascular insufficiency. a double blind trial of Cetal retard against cinnarizine Münchener Medizinische Wochenschrift 119(43): 1407-1410
Pesendorfer, F.X.; Salocher, C. 1983: Experiences with a cimetidine depot preparation (Neutronorm retard) in the treatment of peptic ulcer Wiener Medizinische Wochenschrift 133(4-5): 123-124; 126
Pokrovskiĭ, A.V.; Chupin, A.V.; Kalinin, A.A.; Markosian, A.A.; Zamskiĭ, K.S.; Kolosov, R.V. 2003: Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities Angiologiia i Sosudistaia Khirurgiia 9(2): 19-24
Clamp, M.; Holmes, B.; Wilcox, R. 1990: Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension Journal of Human Hypertension 4(5): 557-563
Velasco-Cornejo, I.F.; Mion Júnior, D.; Martin, L.C.; Tinucci, T.; Sampaio, M.; Pascoal, I.J.; Athanázio-Heliodoro, R.C.; Marcondes, M.; Franco, R.J. 1994: Comparative and double-blind study of the efficacy and safety of cilazapril compared to nifedipine retard in the treatment of mild and moderate arterial hypertension Arquivos Brasileiros de Cardiologia 62(3): 159-164
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Geldmacher-von Mallinckrodt, M.; Jacob, G.; Scaller, K.H. 1979: Lithium distribution in body fluids and organs after treatment with Quilonum Retard (R) (lithium carbonate) Veterinary and Human Toxicology 21 Suppl: 187-190
Wilms, R. 1975: Experiences with Vertigo-Vomex retard in the treatment of vertigo and tinnitus Die Medizinische Welt 26(16): 785-787
Moser, U.; Waldburger, M.; Schwarz, H.A.; Gobelet, C.A. 1989: Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism Schweizerische Rundschau für Medizin Praxis 78(10): 263-269
Kirby, B.J.; Kitchin, N.R. 1999: A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension International Journal of Clinical Practice 53(5): 339-343